Report copyright - J.P. Morgan Healthcare Conference Howard Robin President & CEO · TLR 7/8 Agonist Multiple Solid Tumors Phase 1/2 studies ongoing. A next generation opioid molecule . Chronic Pain
Please pass captcha verification before submit form